Email address
[email protected]Contact number
+1 650 493 9300Provided by Wilson Sonsini Goodrich & Rosati
Wilson Sonsini's legacy of life sciences industry leadership dates back to the formative years of the biotech and medical device sectors, when bold new companies first started to develop important life changing and life saving products and solutions. Since then, the firm has earned its leadership position in the life sciences sector through our representation of innovative companies in the biotechnology, medical devices, and pharmaceuticals sectors, as well as our 40-plus-year history of working closely with the scientists and entrepreneurs who started and grew the companies into thriving businesses. We also have an equally long history of representing sophisticated investors and funding sources that finance entities across the life sciences industry.
Today, the firm's life sciences practice—one of the largest in the U.S.—is anchored by a multi-disciplinary team of more than 275 professionals, including attorneys, patent agents, and scientific advisors. A substantial number of our practitioners have advanced degrees in biology, chemistry, engineering, or other scientific fields. Similarly, a large number of our professionals have experience working in laboratory, medical, or research facilities. The team also includes attorneys who have served as in-house legal counsel for major life sciences companies, or have held senior positions at U.S. federal agencies, including the U.S. Patent and Trademark Office (USPTO) and the Patent Trial and Appeal Board (PTAB).
Provided by Chambers
Wilson Sonsini Goodrich & Rosati is highlighted for its strong West Coast presence and prowess with regard to patent litigation and prosecution. The firm is acclaimed for experience advising on IP-led M&A and strategic collaborations, and is frequently engaged by early-stage companies to assist with stock offerings.
Provided by Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati advised biopharmaceutical company DICE Therapeutics in an acquisition by Eli Lilly for a purchase price of approximately $2.4 billion.
Provided by Chambers
"The Wilson Sonsini team has impressive experience and an ability to handle complex matters while creatively problem solving."
"The Wilson Sonsini team has impressive experience and an ability to handle complex matters while creatively problem solving."
Provided by Chambers
Kenneth Clark advises biotechnology businesses on the full span of corporate transactional processes, such as partnerships and strategic alliances, financings and spinouts, and mergers and acquisitions.